This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Desloratadine | Cetirizine | |
|---|---|---|
| Active Substances | DESLORATADINE | CETIRIZINE HYDROCHLORIDE |
| ATC Code | R06AX27 | R06AE07 |
| Manufacturer | BAYER INC | JAMP PHARMA CORPORATION |
| Indications | ( ARTG ) The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate., The relief of symptoms associated with perennial allergic rhinitis., The symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria. | — |
| Side Effects | You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems | — |
Desloratadine (INN: DESLORATADINE, ATC R06AX27) and Cetirizine (INN: CETIRIZINE HYDROCHLORIDE, ATC R06AE07) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.